Literature DB >> 22774996

Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.

G Cristina Brailoiu1, Elena Deliu, Andrei A Tica, Vineet C Chitravanshi, Eugen Brailoiu.   

Abstract

Urocortin 3 (also known as stresscopin) is an endogenous ligand for the corticotropin-releasing factor receptor 2 (CRF(2)). Despite predominant G(s) coupling of CRF(2), promiscuous coupling with other G proteins has been also associated with the activation of this receptor. As urocortin 3 has been involved in central cardiovascular regulation at hypothalamic and medullary sites, we examined its cellular effects on cardiac vagal neurons of nucleus ambiguus, a key area for the autonomic control of heart rate. Urocortin 3 (1 nM-1000 nM) induced a concentration-dependent increase in cytosolic Ca(2+) concentration that was blocked by the CRF(2) antagonist K41498. In the case of two consecutive treatments with urocortin 3, the second urocortin 3-induced Ca(2+) response was reduced, indicating receptor desensitization. The effect of urocortin 3 was abolished by pre-treatment with pertussis toxin and by inhibition of phospolipase C with U-73122. Urocortin 3 activated Ca(2+) influx via voltage-gated P/Q-type channels as well as Ca(2+) release from endoplasmic reticulum. Urocortin 3 promoted Ca(2+) release via inositol 1,4,5 trisphosphate receptors, but not ryanodine receptors. Our results indicate a novel Ca(2+) -mobilizing effect of urocortin 3 in vagal pre-ganglionic neurons of nucleus ambiguus, providing a cellular mechanism for a previously reported role for this peptide in parasympathetic cardiac regulation.
© 2012 The Authors. Journal of Neurochemistry © 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22774996      PMCID: PMC3433571          DOI: 10.1111/j.1471-4159.2012.07869.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  52 in total

Review 1.  International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands.

Authors:  Richard L Hauger; Dimitri E Grigoriadis; Mary F Dallman; Paul M Plotsky; Wylie W Vale; Frank M Dautzenberg
Journal:  Pharmacol Rev       Date:  2003-03       Impact factor: 25.468

Review 2.  Neuronal calcium signaling.

Authors:  M J Berridge
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

3.  Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neurons.

Authors:  G Cristina Brailoiu; Elena Deliu; Robert Hooper; Nae J Dun; Ashiwel S Undieh; Martin W Adler; Khalid Benamar; Eugen Brailoiu
Journal:  Drug Alcohol Depend       Date:  2011-12-21       Impact factor: 4.492

4.  An increase in intracellular free calcium ions by nicotinic acetylcholine receptors in a single cultured rat cortical astrocyte.

Authors:  Hirotaka Oikawa; Noritaka Nakamichi; Yuki Kambe; Masato Ogura; Yukio Yoneda
Journal:  J Neurosci Res       Date:  2005-02-15       Impact factor: 4.164

5.  Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning.

Authors:  Thomas Blank; Ingrid Nijholt; Dimitris K Grammatopoulos; Harpal S Randeva; Edward W Hillhouse; Joachim Spiess
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

6.  Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells.

Authors:  Frank M Dautzenberg; Eric Gutknecht; Ilse Van der Linden; J Alberto Olivares-Reyes; Franz Dürrenberger; Richard L Hauger
Journal:  Biochem Pharmacol       Date:  2004-11-01       Impact factor: 5.858

7.  NAADP-mediated channel 'chatter' in neurons of the rat medulla oblongata.

Authors:  G Cristina Brailoiu; Eugen Brailoiu; Raman Parkesh; Antony Galione; Grant C Churchill; Sandip Patel; Nae J Dun
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

Review 8.  The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology.

Authors:  Edward W Hillhouse; Dimitris K Grammatopoulos
Journal:  Endocr Rev       Date:  2006-02-16       Impact factor: 19.871

9.  Cardiovascular responses to microinjections of urocortins into the NTS: role of inotropic glutamate receptors.

Authors:  Takeshi Nakamura; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-24       Impact factor: 4.733

10.  Excitatory responses of cardiovascular activities to urocortin3 administration into the PVN of the rat.

Authors:  Xia Li; MingXin Fan; Linlin Shen; YinXiang Cao; DaNian Zhu; Zhen Hong
Journal:  Auton Neurosci       Date:  2010-01-08       Impact factor: 3.145

View more
  13 in total

Review 1.  Parasympathetic Vagal Control of Cardiac Function.

Authors:  Jhansi Dyavanapalli; Olga Dergacheva; Xin Wang; David Mendelowitz
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  Effects of VPAC1 activation in nucleus ambiguus neurons.

Authors:  Florin Liviu Gherghina; Andrei Adrian Tica; Elena Deliu; Mary E Abood; G Cristina Brailoiu; Eugen Brailoiu
Journal:  Brain Res       Date:  2016-12-30       Impact factor: 3.252

3.  Modulation of cardiac vagal tone by bradykinin acting on nucleus ambiguus.

Authors:  Eugen Brailoiu; Matthew McGuire; Shadaria A Shuler; Elena Deliu; Jeffrey L Barr; Mary E Abood; G Cristina Brailoiu
Journal:  Neuroscience       Date:  2017-09-23       Impact factor: 3.590

4.  Nesfatin-1 activates cardiac vagal neurons of nucleus ambiguus and elicits bradycardia in conscious rats.

Authors:  G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Joseph E Rabinowitz; Douglas G Tilley; Khalid Benamar; Walter J Koch; Eugen Brailoiu
Journal:  J Neurochem       Date:  2013-07-19       Impact factor: 5.372

5.  Bradycardic effects of microinjections of urocortin 3 into the nucleus ambiguus of the rat.

Authors:  Vineet C Chitravanshi; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-09-26       Impact factor: 3.619

6.  Frontline Science: Corticotropin-releasing factor receptor subtype 1 is a critical modulator of mast cell degranulation and stress-induced pathophysiology.

Authors:  Saravanan Ayyadurai; Amelia J Gibson; Susan D'Costa; Elizabeth L Overman; Laura J Sommerville; Ashwini C Poopal; Emily Mackey; Yihang Li; Adam J Moeser
Journal:  J Leukoc Biol       Date:  2017-07-06       Impact factor: 4.962

7.  Urotensin II promotes vagal-mediated bradycardia by activating cardiac-projecting parasympathetic neurons of nucleus ambiguus.

Authors:  Gabriela Cristina Brailoiu; Elena Deliu; Joseph E Rabinowitz; Douglas G Tilley; Walter J Koch; Eugen Brailoiu
Journal:  J Neurochem       Date:  2014-03-06       Impact factor: 5.372

8.  Aldosterone increases cardiac vagal tone via G protein-coupled oestrogen receptor activation.

Authors:  G Cristina Brailoiu; Khalid Benamar; Jeffrey B Arterburn; Erhe Gao; Joseph E Rabinowitz; Walter J Koch; Eugen Brailoiu
Journal:  J Physiol       Date:  2013-07-22       Impact factor: 5.182

9.  Bradycardic effects mediated by activation of G protein-coupled estrogen receptor in rat nucleus ambiguus.

Authors:  G Cristina Brailoiu; Jeffrey B Arterburn; Tudor I Oprea; Vineet C Chitravanshi; Eugen Brailoiu
Journal:  Exp Physiol       Date:  2012-10-26       Impact factor: 2.969

10.  Intracellular endothelin type B receptor-driven Ca2+ signal elicits nitric oxide production in endothelial cells.

Authors:  Elena Deliu; G Cristina Brailoiu; Karthik Mallilankaraman; Hong Wang; Muniswamy Madesh; Ashiwel S Undieh; Walter J Koch; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.